Raw Cheddar Recall in E. Coli Outbreak
ATLANTA, Ga. — U.S. and local health authorities say a multistate E. coli O157:H7 outbreak linked to RAW FARM-brand raw cheddar cheese remains active, with investigators tracing illnesses across multiple…
FDA launches adverse event look-up tool
Silver Spring, Maryland — The U.S. Food and Drug Administration says it has launched a unified platform for collecting and analyzing adverse event reports across regulated product categories, with a…
HHS delays preventive care panel again
Basel, Switzerland — Novartis announced positive two-year results from its Phase III APPLAUSE-IgAN study, demonstrating that its oral treatment Fabhalta significantly slowed kidney function decline by nearly 50% in adults…
South Carolina Measles Outbreak Nears End
COLUMBIA, S.C. — South Carolina health officials say the state’s measles outbreak, the largest in the U.S. in decades, can be declared over on April 26 if no new infections…
CDC Pauses Key Infectious Disease Testing
ATLANTA, Ga. — The Centers for Disease Control and Prevention has paused more than two dozen infectious-disease diagnostic tests, including rabies and poxvirus assays, while federal officials conduct what they…
FDA Clears Lilly’s Foundayo Pill
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…
Weekly Extended-Release Buprenorphine Shows Superior Results for Opioid Use Disorder in Pregnancy
CINCINNATI, Ohio — A groundbreaking clinical trial funded by the National Institutes of Health (NIH) HEAL Initiative and conducted through the NIDA Clinical Trials Network has demonstrated that weekly extended-release…
U.S. Measles Outbreaks Threaten Elimination Status
ATLANTA, Georgia — Measles outbreaks across the United States are intensifying as vaccination coverage remains below the level needed to reliably prevent sustained transmission, prompting renewed warnings that the country…
Novartis Drug Fabhalta Slows Kidney Decline by Nearly Half in Phase III Study
Basel, Switzerland — Novartis announced positive two-year results from its Phase III APPLAUSE-IgAN study, demonstrating that its oral treatment Fabhalta significantly slowed kidney function decline by nearly 50% in adults…
FDA lifts age limit for Neffy
SAN DIEGO, Calif. — The U.S. Food and Drug Administration approved a label update for the 1 mg dose of neffy, an epinephrine nasal spray used in allergic emergencies, removing…